C M Bidwell & Associates LTD Eli Lilly & CO Transaction History

C M Bidwell & Associates LTD

$148 Million
Q2 2024

A detailed history of C M Bidwell & Associates LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, C M Bidwell & Associates LTD holds 395 shares of LLY stock, worth $359,185. This represents 0.24% of its overall portfolio holdings.

Number of Shares

395

Previous 395 -0.0%

Holding current value

$359,185

Previous $307,000 16.29%

% of portfolio

0.24%

Previous 0.21%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $232,142 - $310,573	-392 Reduced 49.81%	395 $307,000
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $869 - $1,198	-2 Reduced 0.25%	787 $422,000
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $177,825 - $237,772	507 Added 179.79%	789 $370,000
Q1 2023 May 11, 2023	SELL	$310.63 - $364.82 $97,227 - $114,188	-313 Reduced 52.61%	282 $96,000
Q4 2022 Feb 10, 2023	SELL	$321.55 - $374.67 $34,084 - $39,715	-106 Reduced 15.12%	595 $217,000
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $207,832 - $236,846	701 New	701 $227,000
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $5,000 - $6,188	-42 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$106.92 - $132.43 $343,747 - $425,762	-3,215 Reduced 98.71%	42 $6,000
Q3 2019 Nov 13, 2019	BUY	$106.79 - $116.16 $7,154 - $7,782	67 Added 2.1%	3,257 $364,000
Q2 2019 Aug 07, 2019	SELL	$110.79 - $129.32 $204,961 - $239,242	-1,850 Reduced 36.71%	3,190 $353,000
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $379,010 - $446,123	-3,405 Reduced 40.32%	5,040 $654,000
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $174,735 - $195,756	1,650 Added 24.28%	8,445 $977,000
Q3 2018 Nov 13, 2018	BUY	$85.86 - $107.31 $196,619 - $245,739	2,290 Added 50.83%	6,795 $729,000
Q2 2018 Aug 13, 2018	BUY	$75.7 - $86.88 $341,028 - $391,394	4,505 New	4,505 $384,000

Others Institutions Holding LLY

# of Institutions

3,887

Shares Held

763M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of C M Bidwell & Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on C M Bidwell & Associates LTD with notifications on news.

Account

C M Bidwell & Associates LTD Eli Lilly & CO Transaction History